Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H ( (HK:1858) ) just unveiled an update.
Beijing Chunlizhengda Medical Instruments reported its audited consolidated results for the year ended 31 December 2025, prepared under PRC accounting standards and Hong Kong listing rules. The group’s total assets rose to about RMB3.66 billion from RMB3.47 billion, driven by higher monetary funds, held-for-trading financial assets and growth in fixed assets.
Current assets increased to roughly RMB3.01 billion, supported by a significant rise in cash and a modest uptick in accounts receivable, while inventories edged down slightly. Non-current assets also expanded, reflecting continued investment in fixed assets, construction in progress and right-of-use assets, signaling ongoing capacity building and operational expansion for the medical device manufacturer.
The most recent analyst rating on (HK:1858) stock is a Buy with a HK$16.00 price target. To see the full list of analyst forecasts on Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H stock, see the HK:1858 Stock Forecast page.
More about Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
Beijing Chunlizhengda Medical Instruments Co., Ltd. is a PRC-incorporated joint stock company listed in Hong Kong, operating in the medical instruments sector. The group focuses on manufacturing and selling medical devices and related products, serving healthcare institutions in China and potentially broader regional markets.
Average Trading Volume: 875,921
Technical Sentiment Signal: Sell
Current Market Cap: HK$7.6B
See more data about 1858 stock on TipRanks’ Stock Analysis page.